Advertisement
Screener

COCRYSTAL PHARMA, INC. (COCP) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations

1.2 / 5 stars · 14/60 Roast Me

COCRYSTAL PHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations

COCRYSTAL PHARMA, INC. (COCP) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations of 1.99 million shares for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-09.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations · last filed 2016-11-09

  • COCRYSTAL PHARMA, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2016-09-30 was 1.99M shares.
  • COCRYSTAL PHARMA, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2016-06-30 was 0.00 shares.
  • COCRYSTAL PHARMA, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2016-03-31 was 1.99K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 9 month
2016-09-301.99M shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
1.99M shares
derived: sum of 2 quarters · filed 2016-11-09
1.99M shares
10-Q · filed 2016-11-09
2016-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
1.99K shares
10-Q · filed 2016-08-09
2016-03-311.99K shares
10-Q · filed 2016-05-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
ARTELO BIOSCIENCES, INC. (ARTL)United States$0.023B
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Marker Therapeutics, Inc. (MRKR)United States$0.020B-2.86
Cellectar Biosciences, Inc. (CLRB)United States$0.020B-1.03
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87
NextCure, Inc. (NXTC)United States$0.024B-0.15
Rocket One Inc. (RKTO)United States$0.019B
AYTU BIOPHARMA, INC (AYTU)United States$0.025B-1.62